Therapeutic trials in muscular dystrophy have often been inconclusive. A protocol has been designed which selects patients with Duchenne muscular dystrophy and permits accurate measurement of their status. An integral part of the protocol is a system for checking on the consistency of the data obtained using a computer program.
No takes yet. Share an insight, caveat, or question.
Brooke et al. (1981) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: